Works matching IS 03407004 AND DT 2019 AND VI 68 AND IP 9

Results: 13

Independent expression of circulating and tissue levels of PD-L1: correlation of clusters with tumor metabolism and outcome in patients with non-small cell lung cancer.

Published in:

Cancer Immunology, Immunotherapy, 2019, v. 68, n. 9, p. 1537, doi. 10.1007/s00262-019-02387-9

By:

Grizzi, Fabio;
Castello, Angelo;
Qehajaj, Dorina;
Toschi, Luca;
Rossi, Sabrina;
Pistillo, Daniela;
Paleari, Valentina;
Veronesi, Giulia;
Novellis, Pierluigi;
Monterisi, Simona;
Mineri, Rossana;
Rahal, Daoud;
Lopci, Egesta

Publication type:

Article

Anti-PD-1 therapy combined with chemotherapy in patients with advanced biliary tract cancer.

Published in:

Cancer Immunology, Immunotherapy, 2019, v. 68, n. 9, p. 1527, doi. 10.1007/s00262-019-02386-w

By:

Sun, Danyang;
Ma, Junxun;
Wang, Jinliang;
Han, Chun;
Qian, Yuanyu;
Chen, Guangying;
Li, Xiaoyan;
Zhang, Juan;
Cui, Pengfei;
Du, Wushuang;
Wu, Zhaozhen;
Chen, Shixue;
Zheng, Xuan;
Yue, Zhichao;
Song, Jia;
Gao, Chan;
Zhao, Xiaochen;
Cai, Shangli;
Hu, Yi

Publication type:

Article

Lymphocyte-specific kinase expression is a prognostic indicator in ovarian cancer and correlates with a prominent B cell transcriptional signature.

Published in:

Cancer Immunology, Immunotherapy, 2019, v. 68, n. 9, p. 1515, doi. 10.1007/s00262-019-02385-x

By:

Hinchcliff, Emily;
Paquette, Cherie;
Roszik, Jason;
Kelting, Sarah;
Stoler, Mark H.;
Mok, Samuel C.;
Yeung, Tsz-Lun;
Zhang, Qian;
Yates, Melinda;
Peng, Weiyi;
Hwu, Patrick;
Jazaeri, Amir

Publication type:

Article

Tumor-induced peripheral immunosuppression promotes brain metastasis in patients with non-small cell lung cancer.

Published in:

Cancer Immunology, Immunotherapy, 2019, v. 68, n. 9, p. 1501, doi. 10.1007/s00262-019-02384-y

By:

Li, Yuping D.;
Lamano, Jonathan B.;
Lamano, Jason B.;
Quaggin-Smith, Jessica;
Veliceasa, Dorina;
Kaur, Gurvinder;
Biyashev, Dauren;
Unruh, Dusten;
Bloch, Orin

Publication type:

Article

A phase II study of the L19IL2 immunocytokine in combination with dacarbazine in advanced metastatic melanoma patients.

Published in:

Cancer Immunology, Immunotherapy, 2019, v. 68, n. 9, p. 1547, doi. 10.1007/s00262-019-02383-z

By:

Weide, Benjamin;
Eigentler, Thomas;
Catania, Chiara;
Ascierto, Paolo Antonio;
Cascinu, Stefano;
Becker, Jürgen C.;
Hauschild, Axel;
Romanini, Antonella;
Danielli, Riccardo;
Dummer, Reinhard;
Trefzer, Uwe;
Elia, Giuliano;
Neri, Dario;
Garbe, Claus

Publication type:

Article

TNFSF4 (OX40L) expression and survival in locally advanced and metastatic melanoma.

Published in:

Cancer Immunology, Immunotherapy, 2019, v. 68, n. 9, p. 1493, doi. 10.1007/s00262-019-02382-0

By:

Roszik, Jason;
Markovits, Ettai;
Dobosz, Paula;
Layani, Adi;
Slabodnik-Kaner, Keren;
Baruch, Erez N.;
Ben-Betzalel, Guy;
Grimm, Elizabeth;
Berger, Raanan;
Sidi, Yehezkel;
Schachter, Jacob;
Shapira-Frommer, Ronnie;
Avni, Dror;
Markel, Gal;
Leibowitz-Amit, Raya

Publication type:

Article

Melanoma-conditioned medium promotes cytotoxic immune responses by murine bone marrow-derived monocytes despite their expression of 'M2' markers.

Published in:

Cancer Immunology, Immunotherapy, 2019, v. 68, n. 9, p. 1455, doi. 10.1007/s00262-019-02381-1

By:

Tremble, Liam Friel;
Moore, Anne C.;
Forde, Patrick F.

Publication type:

Article

An optimized retinoic acid-inducible gene I agonist M8 induces immunogenic cell death markers in human cancer cells and dendritic cell activation.

Published in:

Cancer Immunology, Immunotherapy, 2019, v. 68, n. 9, p. 1479, doi. 10.1007/s00262-019-02380-2

By:

Castiello, Luciano;
Zevini, Alessandra;
Vulpis, Elisabetta;
Muscolini, Michela;
Ferrari, Matteo;
Palermo, Enrico;
Peruzzi, Giovanna;
Krapp, Christian;
Jakobsen, Martin;
Olagnier, David;
Zingoni, Alessandra;
Santoni, Angela;
Hiscott, John

Publication type:

Article

A VEGFR2–MICA bispecific antibody activates tumor-infiltrating lymphocytes and exhibits potent anti-tumor efficacy in mice.

Published in:

Cancer Immunology, Immunotherapy, 2019, v. 68, n. 9, p. 1429, doi. 10.1007/s00262-019-02379-9

By:

Xu, Yao;
Zhang, Xinrong;
Wang, Yong;
Pan, Mingzhu;
Wang, Min;
Zhang, Juan

Publication type:

Article

Morphomolecular analysis of the immune tumor microenvironment in human head and neck cancer.

Published in:

Cancer Immunology, Immunotherapy, 2019, v. 68, n. 9, p. 1443, doi. 10.1007/s00262-019-02378-w

By:

Badr, Mohamed;
Jöhrens, Korinna;
Allgäuer, Michael;
Boxberg, Melanie;
Weichert, Wilko;
Tinhofer, Ingeborg;
Denkert, Carsten;
Schirmacher, Peter;
Stenzinger, Albrecht;
Budczies, Jan

Publication type:

Article

Successful combination therapy of systemic checkpoint inhibitors and intralesional interleukin-2 in patients with metastatic melanoma with primary therapeutic resistance to checkpoint inhibitors alone.

Published in:

Cancer Immunology, Immunotherapy, 2019, v. 68, n. 9, p. 1417, doi. 10.1007/s00262-019-02377-x

By:

Rafei-Shamsabadi, David;
Lehr, Saskia;
von Bubnoff, Dagmar;
Meiss, Frank

Publication type:

Article

Safety and efficacy of PD-1 blockade-activated multiple antigen-specific cellular therapy alone or in combination with apatinib in patients with advanced solid tumors: a pooled analysis of two prospective trials.

Published in:

Cancer Immunology, Immunotherapy, 2019, v. 68, n. 9, p. 1467, doi. 10.1007/s00262-019-02375-z

By:

Liang, Lijun;
Wen, Yixuan;
Hu, Rong;
Wang, Lei;
Xia, Youyou;
Hu, Chenxi;
Qiao, Yun;
Geng, Xiaowei;
Chen, Ting;
Fei, Jiayan;
Hui, Kaiyuan;
Jiang, Xiaodong

Publication type:

Article

Anti-CAR-engineered T cells for epitope-based elimination of autologous CAR T cells.

Published in:

Cancer Immunology, Immunotherapy, 2019, v. 68, n. 9, p. 1401, doi. 10.1007/s00262-019-02376-y

By:

Koristka, Stefanie;
Ziller-Walter, Pauline;
Bergmann, Ralf;
Arndt, Claudia;
Feldmann, Anja;
Kegler, Alexandra;
Cartellieri, Marc;
Ehninger, Armin;
Ehninger, Gerhard;
Bornhäuser, Martin;
Bachmann, Michael P.

Publication type:

Article